Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_assertion description "[The endothelin (ET) axis, which includes ET-1, ET-2, ET-3, and 2 G protein-coupled receptor subtypes, ET AR and ET BR, promotes growth and progression of a variety of tumors, such as prostatic, ovarian, renal, pulmonary, colorectal, cervical, breast, lung, bladder, endometrial carcinoma, Kaposi's sarcoma, brain tumors, and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_assertion evidence source_evidence_literature NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_assertion SIO_000772 18758494 NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_assertion wasDerivedFrom befree-20140225 NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_assertion wasGeneratedBy ECO_0000203 NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP868241.RA-HfdduZ_UvIFwj1v43fog4QRhU7bPFjmsScoUhfa85c130_provenance.